Cargando…
Corrigendum: Propofol Protects Myocardium From Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through the AKT/p53 Signaling Pathway
Autores principales: | Li, Shengqiang, Lei, Zhen, Yang, Xiaomei, Zhao, Meng, Hou, Yonghao, Wang, Di, Tang, Shuhai, Li, Jingxin, Yu, Jingui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096490/ https://www.ncbi.nlm.nih.gov/pubmed/35571131 http://dx.doi.org/10.3389/fphar.2022.910421 |
Ejemplares similares
-
Propofol Protects Myocardium From Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through the AKT/p53 Signaling Pathway
por: Li, Shengqiang, et al.
Publicado: (2022) -
Propofol Inhibits Ischemia/Reperfusion-Induced Cardiotoxicity Through the Protein Kinase C/Nuclear Factor Erythroid 2-Related Factor Pathway
por: Li, Shengqiang, et al.
Publicado: (2021) -
Xanthohumol Protects the Rat Myocardium against Ischemia/Reperfusion Injury-Induced Ferroptosis
por: Lin, Jian-Hong, et al.
Publicado: (2022) -
Role of ferroptosis in hypoxic preconditioning to reduce propofol neurotoxicity
por: Chen, Jing, et al.
Publicado: (2023) -
Dapagliflozin alleviates myocardial ischemia/reperfusion injury by reducing ferroptosis via MAPK signaling inhibition
por: Chen, Weixiang, et al.
Publicado: (2023)